Related Experiment Video
Updated: Jan 10, 2026
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
COVID-19, infection fatality rate (IFR) implied by the serology, antibody, testing in New York City
1Department of Economics & Finance, B.I. Moody III College of Business, University of Louisiana at Lafayette, Moody Hall, Room 253, P.O. Box 43709, Lafayette, LA, 70504, USA.
Abstract:
This paper estimates COVID-19 infection fatality rate (IFR) in early 2020 before pharmaceutical interventions were available on a large population in the United States. The better estimates of COVID-19 deaths in New York City and its high COVID-19 infection rate made it ideal to accurately estimate the IFR. Further, we analyze the deaths and infections in New York City to estimate an overall IFR for the United States of 0.86 percent.
More Related Videos
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
08:21Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
Published on: May 23, 2025